GlassScriptPhysician profile
Utsav Bansal
NPI 1851822936
$2,683.03
in general payments reported to CMS, 2019-2025
13 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $179 · 2023: $937 · 2024: $1,193 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,796 · Travel and Lodging: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,796.15 |
| Travel and Lodging | $708.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,301.91 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $371.15 | 2022-2024 | Rezum Generator, Lithovue |
| Calyxo, INC. | $175.60 | 2025 | Cvac Aspiration System |
| Teleflex LLC | $151.01 | 2024 | Urolift |
| Ferring Pharmaceuticals INC. | $134.62 | 2024-2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $133.68 | 2023-2024 | Prolaris |
| Endo Pharmaceuticals INC. | $116.13 | 2023 | Xiaflex |
| Urogen Pharma, INC. | $88.77 | 2022 | |
| Verity Pharmaceuticals INC. | $59.70 | 2024 | Tlando |
| Antares Pharma, INC. | $50.00 | 2023 | Tlando, Xyosted |
| Janssen Biotech, INC. | $41.22 | 2025 | Erleada |
| Angiodynamics, INC. | $36.98 | 2025 | Nanoknife |
| Laborie Medical Technologies Corp. | $22.26 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Utsav Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.